Because it’s
important to have the best possible immunity to face COVID-19 as well as other
diseases.
Early Treatment
Because the
most effective treatments are administered early, at home, at the disease’s
first symptoms.
Long Covid
Because Long
Covid is increasingly common and can be treated. It can also be avoided with
early treatment.
DISCLAIMER: The information contained or presented on this website is for educational purposes only. Information on this site is NOT intended to serve as a substitute for diagnosis, treatment, or advice from a qualified, licensed medical professional.
WHY
EARLY TREATMENT?
In a nutshell, here are key reasons why
early treatment is essential for overcoming COVID-19:
Because any Disease is Best to be Treated Early
COVID-19 is like all diseases, it is best to be treated early. The disease has
several phases. The first one is viral, and there are various outpatient
therapies available to contain viral multiplication, initially in the upper
respiratory tract and then in the lungs. There are also outpatient therapies
that address the early inflammatory phase of the disease, that typically start the
second week after the first symptoms. For most of us, COVID-19 is a very low
risk disease, yet, when treated at first symptoms, your likelihood of survival
and of prompt recovery are even greater. For higher risk patients (for example
over 60 year old, with health issues / comorbidities), treating early is a key
for avoiding complications.
Because Hospitalization is Best to be Avoided
With early outpatient treatment, the
need for hospitalization is considerably reduced. The first outpatient
treatment practice that was studied, in the State of New York, achieved an 85%
reduction in hospital admissions for COVID-19, thanks to a simple therapy
comprising 3 agents, that was actually only prescribed to higher risk patients.
Since then, there has been further progress with early therapies. As long as
the patient presents early, the likelihood of hospitalization for COVID-19 is
very small, compared to the situation where the patient does not receive any
treatment. With early treatment, hospitalization, which is expensive for the
patient and costly to society, is simply not needed in most cases. This
considerably reduces the pressure on health systems. Not treating early is a
form of therapeutic nihilism. There is just no rationale to refrain from
treating COVID-19 early.
Because Long Covid is More Likely Avoided
The development of long term symptoms of
COVID-19, otherwise known as Long Covid, is an unfortunate yet increasingly
prevalent trend in our countries, with people having a variety of more or less
grave symptoms for months, if not years. Long Covid is very much related to an
untreated or poorly treated inflammatory phase of the disease. When COVID-19 is
treated early, patients typically fully recover from the disease, without any
further symptoms, and thereby avoid the Long Covid condition.
Because Transmission Risks are Reduced
When you get COVID-19, you become
typically contagious around when you develop your first symptoms. With early
treatment, you will likely overcome the disease rapidly, with the viral phase
being contained through the treatment. You will also likely receive advice from
your treating doctor about how to best avoid transmitting the disease to others
at your home. Some doctors may even prescribe some prophylaxis therapy for
those who live with you. The outcome is typically a much lower risk of
transmission to others.
QUICK
REFERENCES
News
Covexit.com
McCullough Report
Home Early Treatment Guide
AAPS Home Treatment Guide &
Physicians List
Telemedicine Services for C19 in the USA
https://myfreedoctor.com/ ; https://speakwithanmd.com ; & more on this list.
Early Treatment Protocol Examples
Drs Fareed & Tyson Early
Treatment Protocol
FLCCC iMask+ Prevention & Early
Treatment Protocol
Dr Fareed’s Nursing Home Protocol
Dr Zelenko’s Prevention & Early
Treatment Protocol
Dr Sankhara Chetty’s 8th Day Therapy
Prevention/Prophlaxis Protocol Examples
FLCCC Prophylaxis
Zelenko Prophylaxis
See also LINK
Long
Covid
Therapeutic information about Long Covid
is scarce; yet check LINK
Key Webinars
The Practice of Early Outpatient
Treatment, Prof. McCullough,
Dr Chetty & Dr Bernstein:
The Prevention & Outpatient
Treatment of COVID-19, with Prof. Marik
Prophylaxis & Early Treatment in
Nursing Homes –
a Webinar with Dr Robin Armstrong and Dr George Fareed
Early Outpatient Treatment Algorithm
for COVID-19 –
with Professor McCullough
Follow Us on Social Media
Twitter: jpkiekens
Mewe: https://mewe.com/join/covexit
Telegram: https://t.me/covexitgroup
Key
Academic References
Multifaceted highly targeted sequential multidrug treatment of early ambulatory
high-risk SARS-CoV-2 infection (COVID-19), by Peter A McCullough & al. LINK
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the
Prophylaxis and Treatment of COVID-19, by Pierre Kory & al. LINK
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose
hydroxychloroquine and azithromycin: a retrospective case series study, by
Derwand & al. LINK
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2,
open-label, randomised controlled trial, by Sanjay Ramakrishnan et al. LINK
Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease
19, by Seftel & Boulware. LINK
Directory / live meta-analysis studies: https://c19early.com/
Video Interviews & Webinars
While
we have weekly meetings on ClubHouse, we have top notch interviews, webinars
and other online events, that you can access from our website.
SEE DETAILS https://covexit.com/category/webinars/